American Century Companies Inc Alx Oncology Holdings Inc Transaction History

American Century Companies Inc

  • $167 Billion
  • Q3 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 07, 2024
SELL
$5.84 - $17.56 $34,911 - $104,973
-5,978 Reduced 20.15%
23,685 $142,000
Q1 2024

May 14, 2024
BUY
$10.95 - $16.79 $92,713 - $142,160
8,467 Added 39.95%
29,663 $330,000
Q4 2023

Feb 13, 2024
BUY
$4.81 - $15.38 $101,952 - $325,994
21,196 New
21,196 $315,000
Q3 2023

Nov 13, 2023
BUY
$4.19 - $7.35 $42,976 - $75,388
10,257 New
10,257 $49,000

Others Institutions Holding ALXO

# of Institutions
101
Shares Held
39.7M
Call Options Held
134K
Put Options Held
17.4K
View Full List

About ALX ONCOLOGY HOLDINGS INC

ALXO Quotes by TradingView
  • Ticker ALXO
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 40,747,100
  • Market Cap $74.6M
  • Description
  • ALX Oncology Holdings Inc., a clinical-stage immuno-oncology company, focuses on developing therapies for patients fighting cancer. Its lead product candidate is ALX148, a CD47 blocking therapeutic that is in Phase 1b/2 clinical trial used for the treatment of myelodysplastic syndromes; and for the treatment of acute myeloid leukemia and non-Hod...
More about ALXO
Track This Portfolio

Track American Century Companies Inc Portfolio

Follow American Century Companies Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of American Century Companies Inc, based on Form 13F filings with the SEC.

News

Stay updated on American Century Companies Inc with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email